Product Information
LANSOPRAZOL-AMOXICIL-CLARITHRO is a generic product labeled by Rising Pharma Holdings Inc., priced at $6.0422 per EA under NDC 57237000114. Its NADAC has been published 390 times since Aug 9, 2017.
FDA first approved this application on Oct 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Rising Pharma Holdings Inc.NDC
57237000114
Classification
Generic
Dosage Form
KIT
Effective Date
11/19/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA206006FDA Approved
10/7/2016
TE Code
AB
On Market Since
10/14/2016
Price Statistics
The NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has been published 390 times since Aug 9, 2017, and over the history we have for it it has risen 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0422 per EA |
|---|---|
| All-time high | $6.1168 (Nov 12, 2025) |
| All-time low | $2.3156 (Dec 19, 2018) |
| 52-week high | $6.1168 |
| 52-week low | $6.0422 |
| Median price | $4.7645 |
| Average price | $4.2743 |
| Largest weekly change | +62.1% (Oct 14, 2020) |
| Weeks tracked | 390 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lansoprazole, Amoxicillin, Clarithromycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOL-AMOXICIL-CLARITHRO?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOL-AMOXICIL-CLARITHRO, manufactured by Rising Pharma Holdings Inc., is $6.0422 per EA (NDC 57237000114), effective Aug 19, 2026.
How has the price of LANSOPRAZOL-AMOXICIL-CLARITHRO changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has risen 89.5%. It has been tracked across 390 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOL-AMOXICIL-CLARITHRO?
Since Aug 9, 2017, the NADAC for LANSOPRAZOL-AMOXICIL-CLARITHRO has ranged from a low of $2.3156 (Dec 19, 2018) to a high of $6.1168 (Nov 12, 2025), with a median of $4.7645 per EA.
Are there cheaper alternatives to LANSOPRAZOL-AMOXICIL-CLARITHRO?
No other NADAC-published product currently shares the active ingredient and strength of LANSOPRAZOL-AMOXICIL-CLARITHRO in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LANSOPRAZOL-AMOXICIL-CLARITHRO?
LANSOPRAZOL-AMOXICIL-CLARITHRO (NDC 57237000114) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.